A topical cream activated the skin's immune defenses and suppressed tumor growth in two preclinical models of cutaneous ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

A new study by researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain ...

LOS ANGELES--(BUSINESS WIRE)--Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for the treatment of obesity; and ii) the ...

VANCOUVER, Washington, Feb. 01, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Pancreatic malignancies remain some of the most challenging cancers to treat. Experts anticipate over 52,000 pancreatic cancer-related deaths this year. Sadly, the five-year survival rate for ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown to preferentially accumulate in mouse retinas, eyes, and ...

The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PH Lanifibranor was observed to decrease portal pressure by ...

PMGC Holdings Inc. (Nasdaq: ELAB) ("PMGC" or the "Company") today announced the initiation of a preclinical study for EL-32, an engineered probiotic ...

CHICAGO, February 24, 2026--(BUSINESS WIRE)--Grove Biopharma, a private biotechnology company engineering protein-like polymers (PLPs) – a new class of multifunctional biologics designed to address ...

Our faculty-led laboratories investigate a broad range of conditions spanning kidney stone disease, endourologic disorders, and urologic cancers. Research within the department encompasses all stages ...

- Single-dose administration of LAE102 by IV or SC injection demonstrated a favorable safety profile in the healthy participants as well as robust and prolonged target engagement in the healthy ...